CHU de Poitiers, Pôle Régional de Cancérologie

Poitiers 86021

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb — Running, not enrolling